As part of World Malaria Day 2022, we interview Karine Le Roch PH.D., about her latest research into how novel antimalarial therapeutic strategies could be...
Reaction Biology, an industry-leading provider of drug discovery services, today announced that twelve abstracts highlighting data from the Company’s oncology drug discovery services platform will...
Venomtech is collaborating with Charles River Laboratories, International Inc. to help drug developers explore venom-derived compounds for a wide range of therapeutic targets. This newly...
The coronavirus disease 2019 (COVID-19) has frustrated many healthcare workers during the early pandemic not just because of its high transmission rate but because of...
On Thursday, April 7, the Centers for Medicare and Medicaid (CMS) formalized its plan to cover the anti-amyloid drug Aduhelm only for patients enrolled in...
For patients with cancer, the tumor-killing power of chemotherapeutic drugs is a double-edged sword. While many cancer drugs kill tumor cells, they can also harm...
In a new study at University of California, Irvine, researchers have revealed the impact of native lipids on rhodopsin signaling and regeneration, which may usher...
Arrayjet, a leading provider of inkjet liquid-handling solutions, today introduced Mercury, a new core range of five instruments for ultra-low-volume liquid dispensing. The new print...
In a recent Reviews in Medical Virology article, scientists discuss the pathogenic characteristics of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and available therapeutic...
A recent International Journal of Molecular Sciences review article succinctly summarizes previous studies leading to the development of furin inhibitors as potential therapeutics for treating coronavirus...
In this interview, we speak to Maggie Vantangoli Policelli, head of marketing at Araceli Biosciences, about their latest product the Araceli Endeavor, and how it’s...
[*] [**]Most early treatments against the coronavirus disease 2019 (COVID-19) have targeted the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, as it is...
